{"gene":"PARL","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2006,"finding":"PARL, an inner mitochondrial membrane rhomboid protease, is required for the generation of a soluble intermembrane space (IMS) form of OPA1; loss of PARL results in reduced IMS-OPA1, faster apoptotic cristae remodeling, and increased cytochrome c release, placing PARL upstream of OPA1-dependent cristae remodeling in the intrinsic apoptosis pathway.","method":"Parl knockout mouse (Parl-/- cells), OPA1 fractionation, cytochrome c release assay, complementation with IMS-targeted OPA1","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic rescue (IMS-OPA1 complementation), KO phenotype with multiple orthogonal readouts (cristae morphology, cytochrome c release, OPA1 fractionation), replicated conceptually in multiple subsequent studies","pmids":["16839884"],"is_preprint":false},{"year":2004,"finding":"PARL undergoes autocatalytic cleavage at two N-terminal sites (alpha-site at positions 52-53 and beta-site at positions 77-78); beta-cleavage is developmentally controlled, dependent on PARL I-CliP activity supplied in trans, and releases a nuclear-targeted peptide called Pbeta.","method":"Site-directed mutagenesis of cleavage sites, in vitro cleavage assay, subcellular fractionation, nuclear localization tracking of Pbeta","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis and fractionation in single study; Pbeta nuclear targeting demonstrated but functional consequence not fully established","pmids":["14732705"],"is_preprint":false},{"year":2006,"finding":"Phosphorylation of three residues in the vertebrate-specific Pbeta domain of PARL (Ser-65, Thr-69, Ser-70) impairs beta-cleavage at position Ser77-Ala78 that is required for PARL-induced mitochondrial fragmentation; thus phosphorylation state of the Pbeta domain regulates PARL proteolytic activity and mitochondrial morphology.","method":"Phosphomimetic and phospho-ablative mutagenesis of PARL, mitochondrial morphology imaging, in-cell cleavage assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with functional readout (mitochondrial morphology), single lab, two orthogonal methods","pmids":["17116872"],"is_preprint":false},{"year":2008,"finding":"PARL forms a complex with HAX1 and HtrA2; HAX1 presents HtrA2 to PARL, which cleaves/processes HtrA2 to its active form in the mitochondrial intermembrane space, and processed HtrA2 prevents Bax-dependent apoptosis in lymphocytes and neurons.","method":"Co-immunoprecipitation, Hax1 and Parl knockout mice, lymphocyte and neuronal apoptosis assays, HtrA2 processing Western blot","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse models with defined phenotype, Co-IP; contested by a subsequent study (PMID:19680265) arguing HAX1-PARL interaction is artifactual, lowering confidence","pmids":["18288109"],"is_preprint":false},{"year":2010,"finding":"PARL mediates cleavage of PINK1 in a mitochondrial membrane potential-dependent manner; in healthy mitochondria with intact potential, PARL cleaves PINK1 to generate a ~60 kDa form inside mitochondria; upon membrane potential dissipation, PARL-mediated cleavage is blocked and full-length PINK1 (63 kDa) accumulates on the outer mitochondrial membrane where it recruits Parkin.","method":"PARL knockdown (siRNA/KO cells), membrane potential dissipation (CCCP), PINK1 Western blot, mitochondrial fractionation, Parkin recruitment assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with defined molecular phenotype, replicated by multiple independent groups (PMIDs 21138942, 21426348, 21355049)","pmids":["21115803"],"is_preprint":false},{"year":2010,"finding":"PINK1 is cleaved by PARL between amino acids Ala-103 and Phe-104 to generate ΔN-PINK1; PINK1 physically interacts with PARL; loss of PARL results in aberrant PINK1 cleavage; N-terminal PD-associated PINK1 mutations alter the ratio of full-length to ΔN-PINK1.","method":"N-terminal sequencing of cleavage products, PARL knockdown, Co-immunoprecipitation of PINK1 and PARL, PD mutant analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — cleavage site mapped by N-terminal sequencing, Co-IP, loss-of-function, multiple independent replications","pmids":["21138942"],"is_preprint":false},{"year":2011,"finding":"PARL cleaves PINK1 within its conserved transmembrane membrane anchor, releasing mature PINK1 into the cytosol or IMS; depolarization blocks canonical PINK1 import and PARL-catalyzed processing; two PD-causing PINK1 mutations decrease PARL-mediated processing.","method":"In-cell cleavage assay, membrane potential dissipation, PARL KO/knockdown, PINK1 localization imaging","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods, consistent with parallel independent reports, transmembrane cleavage site established","pmids":["21426348"],"is_preprint":false},{"year":2011,"finding":"PARL's catalytic activity is required for normal PINK1 proteolytic processing and localization; PARL deficiency impairs PARKIN recruitment to mitochondria; a novel PARL missense mutation found in PD patients in a functional domain of the PARL N-terminus is insufficient to rescue PARKIN recruitment.","method":"Catalytically dead PARL mutant, PARL knockdown, PARKIN recruitment assay, PINK1 localization fractionation","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — catalytic mutant rescue experiment, PARKIN recruitment functional readout, human PD mutation validation","pmids":["21355049"],"is_preprint":false},{"year":2012,"finding":"PARL cleaves PGAM5 in its N-terminal transmembrane domain in response to mitochondrial membrane potential loss; PARL dissociates from PINK1 and reciprocally associates with PGAM5 upon membrane potential loss, demonstrating stress-dependent substrate switching.","method":"PARL knockdown, membrane potential dissipation (CCCP), Co-immunoprecipitation of PARL with PINK1 and PGAM5, PGAM5 cleavage Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP demonstrating substrate switch, loss-of-function, multiple readouts in single study","pmids":["22915595"],"is_preprint":false},{"year":2015,"finding":"Ablation of PARL causes retrograde translocation of a PINK1 import intermediate from the IMS; this intermediate is rerouted to the outer mitochondrial membrane to recruit PARK2/Parkin, phenocopying mitophagy induction by uncoupling agents; pathogenic PINK1 mutants not cleaved by PARL show reduced kinase activity and impaired PARK2-mediated mitophagy.","method":"PARL knockout, PINK1 localization fractionation, Parkin recruitment assay, PINK1 mutant analysis","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO with defined retrograde translocation mechanism, multiple PINK1 mutants tested, consistent with prior independent studies","pmids":["26101826"],"is_preprint":false},{"year":2016,"finding":"SLP2 anchors a large protease complex (SPY complex: SLP2-PARL-YME1L) at the mitochondrial inner membrane; association with SLP2 regulates PARL-mediated processing of PINK1 and PGAM5; SLP2 also restricts OMA1 activity, preventing OMA1-mediated PGAM5 and OPA1 cleavage under non-stress conditions.","method":"Co-immunoprecipitation, Blue Native PAGE, PARL/SLP2 knockdown, PINK1/PGAM5/OPA1 processing Western blot","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, native complex isolation, multiple substrates tested, functional consequence of complex disruption shown","pmids":["27737933"],"is_preprint":false},{"year":2017,"finding":"PARL cleaves the pro-apoptotic protein Smac/DIABLO by intramembrane proteolysis, generating an N-terminal IAP-binding motif required for Smac's apoptotic activity; loss of PARL impairs Smac proteolytic maturation and prevents Smac from binding XIAP, reducing apoptosis.","method":"PARL-based proteomics/substrate screen, PARL KO cells, in vitro cleavage assay, XIAP binding assay, apoptosis rescue with Smac peptidomimetics or cytosolic cleaved Smac","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — proteomics-based substrate identification, in vitro cleavage, KO rescue, XIAP binding assay; multiple orthogonal methods","pmids":["28288130"],"is_preprint":false},{"year":2017,"finding":"PDK2 phosphorylates PARL and regulates its N-terminal autocatalytic beta-cleavage in response to mitochondrial ATP depletion; beta-cleavage produces a less active PARL form (PACT), and PDK2-mediated phosphorylation negatively regulates PINK1/PARKIN-dependent mitophagy through this mechanism.","method":"PDK2 kinase assay with PARL substrate, phospho-PARL detection, mitophagy reporter assay, PARL beta-cleavage Western blot","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase assay and functional mitophagy readout, single lab, two orthogonal methods","pmids":["28178523"],"is_preprint":false},{"year":2018,"finding":"PARL cleaves the lipid transfer protein STARD7 during mitochondrial import; cleavage partitions STARD7 between the cytosol and the mitochondrial IMS; negatively charged residues in STARD7 serve as a sorting signal; mitochondrial STARD7 is necessary for phosphatidylcholine accumulation in the inner membrane and for maintenance of respiration and cristae morphogenesis.","method":"PARL KO cells, STARD7 fractionation, phosphatidylcholine lipid analysis, cristae morphology EM, respiratory chain assay, STARD7 sorting signal mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO with multiple orthogonal functional readouts (lipid analysis, EM, respiration), mutagenesis of sorting signal, single study with comprehensive mechanistic follow-up","pmids":["29301859"],"is_preprint":false},{"year":2018,"finding":"PARL deficiency in mouse causes defects in Complex III activity and coenzyme Q biosynthesis in the nervous system; PARL is required for stable expression of TTC19 (required for Complex III activity) and COQ4 (essential for CoQ biosynthesis); genetic modification of PINK1 or PGAM5 does not rescue this neurological phenotype.","method":"Conditional Parl KO mouse (nervous system-specific), respiratory chain enzyme activity assay, CoQ HPLC measurement, TTC19/COQ4 protein levels by Western blot, electron microscopy","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO mouse with multiple biochemical readouts, epistasis experiment (PINK1/PGAM5 double KO), multiple orthogonal methods","pmids":["30578322"],"is_preprint":false},{"year":2019,"finding":"PHB2-mediated mitophagy is dependent on PARL; PHB2 physically interacts with PARL; PHB2 depletion activates PARL, which processes PGAM5; the PHB2-PARL-PGAM5-PINK1 axis constitutes a novel pathway for PHB2-mediated mitophagy.","method":"Co-immunoprecipitation of PHB2 and PARL, PARL activity assay upon PHB2 depletion, PINK1 stability assay, Parkin recruitment, PGAM5 processing Western blot","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, loss-of-function, functional mitophagy readout, single lab","pmids":["31177901"],"is_preprint":false},{"year":2021,"finding":"Purified recombinant human PARL in proteoliposomes cleaves PINK1, PGAM5, and Smac/DIABLO; PARL activity is enhanced by cardiolipin; the beta-cleavage truncated form of PARL is more active than full-length for all three substrates; PARL prefers substrates with a bulky side chain (Phe) at the P1 position, distinct from bacterial rhomboids.","method":"In vitro reconstitution of PARL in proteoliposomes, FRET-based kinetic assay, cardiolipin supplementation, multiplex peptide substrate profiling (228 peptides), comparison of full-length vs beta-cleaved PARL","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with kinetic characterization, substrate preference profiling with 228 peptides, multiple substrates and PARL forms tested","pmids":["33556373"],"is_preprint":false},{"year":2022,"finding":"PGAM5 cleavage by PARL is governed by polar transmembrane residues distant from the cleavage site; an N-terminal amphipathic helix followed by a kink and C-terminal transmembrane helix harboring the scissile bond are key for productive PARL interaction; membrane potential uncoupling triggers PGAM5 disassembly from oligomers to monomers, which are then cleaved by PARL.","method":"NMR structural analysis of PGAM5 transmembrane domain, site-directed mutagenesis of polar residues, membrane potential dissipation, PGAM5 oligomeric state analysis, PARL cleavage assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural analysis combined with mutagenesis and functional cleavage assay, single lab but multiple orthogonal methods","pmids":["35921890"],"is_preprint":false},{"year":2022,"finding":"Pharmacological inhibition of PARL using novel ketoamide inhibitors leads to robust activation of the PINK1/Parkin pathway without major secondary effects on mitochondrial properties, demonstrating that acute PARL inhibition (as opposed to genetic deficiency) is sufficient to boost PINK1/Parkin-dependent mitophagy.","method":"Ketoamide inhibitor synthesis, PARL inhibition in cells, PINK1 intermediate accumulation Western blot, Parkin activation assay","journal":"Journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chemical biology approach with functional readouts, single study, two methods","pmids":["36540942"],"is_preprint":false},{"year":2023,"finding":"CHCHD10 wild-type suppresses PARL activity through direct interaction with PARL, stabilizing PINK1 levels; ALS/FTD-linked CHCHD10 mutations (R15L and S59L) reduce PINK1 levels by increasing PARL activity; CHCHD10 mutations impair mitophagy flux and mitochondrial Parkin recruitment.","method":"Co-immunoprecipitation of CHCHD10 and PARL, PINK1 level assay, Parkin recruitment assay, in vivo mouse models, human FTD brain tissue analysis","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, in vivo models, human tissue validation, single lab","pmids":["38132101"],"is_preprint":false},{"year":2009,"finding":"In vivo, HAX1 and PARL are confined to distinct cellular compartments, and their in vitro interaction is artifactual; the mechanistic coupling of HAX1 to PARL as proposed by Chao et al. is not supported by in vivo evidence.","method":"Subcellular fractionation, in vivo co-immunoprecipitation, sequence/secondary structure analysis","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — fractionation and in vivo Co-IP as negative/contradictory evidence, single lab; contradicts PMID:18288109","pmids":["19680265"],"is_preprint":false},{"year":2013,"finding":"PARL binds HtrA2 in mitochondria of normal neurons; after cerebral ischemia, PARL expression decreases, PARL-HtrA2 binding is lost, processed HtrA2 is reduced in mitochondria and released into cytosol where it binds XIAP; PARL siRNA inhibits HtrA2 processing and worsens ischemic neuronal injury.","method":"Co-immunoprecipitation of PARL and HtrA2, subcellular fractionation, siRNA knockdown, neuronal injury assay in global cerebral ischemia mouse model","journal":"Journal of cerebral blood flow and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, siRNA KD with functional phenotype, in vivo model; single lab","pmids":["23921894"],"is_preprint":false},{"year":2012,"finding":"In Parl-/- cells, accumulation of IMS-OPA1 upon mild heat shock conditioning is blunted, preventing the increase in OPA1 oligomers and the acquisition of cellular resistance to subsequent apoptotic stimuli; the OPA1/PARL-dependent pathway of cristae remodeling is required for the heat shock adaptive response.","method":"Parl-/- cells, OPA1 fractionation, OPA1 oligomer analysis, heat shock conditioning protocol, cytochrome c release assay","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO cells with defined mechanistic pathway, single lab, two orthogonal methods","pmids":["22579715"],"is_preprint":false},{"year":2025,"finding":"PARL interacts with the orphan nuclear receptor Nur77 at the mitochondria; Nur77 stabilizes PARL-BCL-2 complexes to suppress apoptosis; AlphaFold2 structural modeling identified a PARL alpha-helix essential for Nur77 binding; disrupting this interface abolishes BCL-2 stabilization and promotes neuronal death.","method":"Co-immunoprecipitation of PARL-Nur77-BCL-2, AlphaFold2 structural modeling, PARL knockdown and Nur77 overexpression in MPTP mouse model, subcellular tracking of Nur77","journal":"Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP and in vivo rescue but structural data is computational prediction only, single lab, mechanistic novelty not yet replicated","pmids":["41052999"],"is_preprint":false},{"year":2025,"finding":"PARL modulation (overexpression or silencing) significantly affects mitochondrial calcium uptake without influencing cytosolic calcium transients or mitochondrial membrane potential; PARL does not directly interact with MICU1 or MICU2 (mtCU regulators), but alters their protein levels in monomeric or dimeric forms, suggesting indirect modulation of the mitochondrial calcium uniporter complex.","method":"PARL overexpression and silencing, mitochondrial and cytosolic calcium imaging, Co-immunoprecipitation for MICU1/MICU2/MCU/EMRE interaction, Western blot for protein levels","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, Co-IP negative for direct interaction, indirect mechanism inferred from protein level changes without mechanistic detail","pmids":["40484322"],"is_preprint":false}],"current_model":"PARL is a mitochondrial inner membrane serine rhomboid intramembrane protease (with a catalytic Ser/His dyad) that cleaves multiple substrates—including PINK1 (at Ala103-Phe104), PGAM5, Smac/DIABLO, STARD7, OPA1, and HtrA2—in a manner regulated by mitochondrial membrane potential, cardiolipin, and N-terminal autocatalytic beta-cleavage (itself controlled by PDK2 phosphorylation); by cleaving PINK1 in healthy mitochondria PARL promotes PINK1 degradation and suppresses mitophagy, while membrane potential dissipation blocks PARL-mediated PINK1 processing and allows full-length PINK1 to accumulate on the outer membrane and recruit Parkin for mitophagy; PARL also generates IMS-OPA1 to prevent cristae remodeling and apoptotic cytochrome c release, processes Smac to produce its IAP-binding motif for caspase activation, cleaves STARD7 to regulate phosphatidylcholine homeostasis and cristae integrity, and is organized into the SPY complex with SLP2 and YME1L that coordinates substrate selection and IM protease activity."},"narrative":{"mechanistic_narrative":"PARL is a serine rhomboid intramembrane protease of the mitochondrial inner membrane that controls mitochondrial quality control, cristae integrity, and apoptosis by regulated cleavage of multiple membrane-embedded substrates [PMID:21115803, PMID:33556373]. Its central role in mitophagy lies in PINK1 processing: in healthy mitochondria with intact membrane potential, PARL cleaves PINK1 within its transmembrane anchor between Ala103 and Phe104 to generate a truncated form destined for degradation, whereas membrane potential dissipation blocks this cleavage, allowing full-length PINK1 to accumulate on the outer membrane and recruit Parkin to drive mitophagy [PMID:21115803, PMID:21138942, PMID:21426348, PMID:26101826]. Loss of PARL catalytic activity impairs PINK1 processing and Parkin recruitment, and PARL-resistant PD-associated PINK1 mutants show reduced kinase activity and defective mitophagy [PMID:21355049, PMID:26101826]. PARL operates as a stress-responsive substrate switch, dissociating from PINK1 and reciprocally engaging PGAM5 upon membrane potential loss, with PGAM5 cleavage further gated by its oligomeric state and transmembrane architecture [PMID:22915595, PMID:35921890]. Beyond mitophagy, PARL generates the soluble IMS form of OPA1 that restrains apoptotic cristae remodeling and cytochrome c release [PMID:16839884], and it cleaves Smac/DIABLO to expose its IAP-binding motif required for XIAP engagement and apoptosis [PMID:28288130], and STARD7 to partition this lipid-transfer protein and sustain inner-membrane phosphatidylcholine, respiration, and cristae morphogenesis [PMID:29301859]. PARL activity is set by N-terminal autocatalytic beta-cleavage—which yields a more active enzyme—modulated by cardiolipin and by PDK2-dependent phosphorylation of the Pbeta domain [PMID:28178523, PMID:33556373, PMID:17116872]. PARL functions within the SPY complex with SLP2 and YME1L, which coordinates substrate selection and restricts competing OMA1 activity [PMID:27737933]. In mouse nervous system, PARL is additionally required for Complex III function and coenzyme Q biosynthesis through stable expression of TTC19 and COQ4, independent of PINK1 or PGAM5 [PMID:30578322].","teleology":[{"year":2004,"claim":"Established that PARL is itself a substrate of its own protease activity, undergoing autocatalytic N-terminal processing that liberates a nuclear-targeted peptide, setting up the idea that PARL activity is self-regulated.","evidence":"Site-directed mutagenesis of alpha/beta cleavage sites, in vitro cleavage, and fractionation tracking the Pbeta peptide","pmids":["14732705"],"confidence":"Medium","gaps":["Functional consequence of nuclear Pbeta not established","How beta-cleavage alters protease activity on substrates not yet defined"]},{"year":2006,"claim":"Defined PARL's first physiological substrate axis by showing it generates soluble IMS-OPA1 to oppose apoptotic cristae remodeling, placing PARL upstream of intrinsic apoptosis.","evidence":"Parl-/- cells, OPA1 fractionation, cytochrome c release assay, IMS-OPA1 complementation rescue","pmids":["16839884"],"confidence":"High","gaps":["Cleavage site within OPA1 by PARL not mapped here","Relationship to other OPA1-processing proteases unresolved"]},{"year":2006,"claim":"Showed PARL activity is regulated by phosphorylation of its vertebrate-specific Pbeta domain, linking beta-cleavage to control of mitochondrial morphology.","evidence":"Phosphomimetic/phospho-ablative PARL mutagenesis with mitochondrial morphology imaging and in-cell cleavage assay","pmids":["17116872"],"confidence":"Medium","gaps":["Kinase responsible not identified in this study","Direct biochemical link between morphology and specific substrate cleavage not shown"]},{"year":2008,"claim":"Proposed PARL processes HtrA2 in an HAX1-presented manner to suppress apoptosis, extending PARL substrates to a pro-apoptotic serine protease.","evidence":"Co-IP, Hax1 and Parl knockout mice, lymphocyte/neuronal apoptosis and HtrA2 processing assays","pmids":["18288109"],"confidence":"Medium","gaps":["HAX1-PARL interaction contested as artifactual by a later study","Direct catalytic cleavage of HtrA2 by PARL not reconstituted"]},{"year":2009,"claim":"Challenged the HAX1-PARL model by showing the two proteins occupy distinct compartments and interact only artifactually in vitro, qualifying the proposed coupling.","evidence":"Subcellular fractionation, in vivo Co-IP, and sequence/structure analysis as contradictory evidence","pmids":["19680265"],"confidence":"Medium","gaps":["Does not exclude PARL-HtrA2 interaction independent of HAX1","Single-lab negative result"]},{"year":2010,"claim":"Identified PINK1 as a membrane-potential-gated PARL substrate, providing the molecular switch that couples mitochondrial health to PINK1 stability and Parkin recruitment.","evidence":"PARL knockdown/KO, CCCP depolarization, PINK1 Western blot, fractionation, and Parkin recruitment; cleavage site mapped at Ala103-Phe104 by N-terminal sequencing","pmids":["21115803","21138942"],"confidence":"High","gaps":["Fate of cleaved PINK1 fragment and its degradation route only partially defined","How depolarization mechanistically blocks cleavage not fully resolved"]},{"year":2011,"claim":"Confirmed PARL cleaves PINK1 within its transmembrane anchor and that catalytic activity is required for proper PINK1 localization and Parkin recruitment, with PD mutations impinging on this processing.","evidence":"Catalytically dead PARL mutant, in-cell cleavage assays, PINK1 localization fractionation, Parkin recruitment, and human PD missense mutation analysis","pmids":["21426348","21355049"],"confidence":"High","gaps":["Disease causality of the PARL missense variant not established beyond functional assay","Precise topology of mature PINK1 after release not fully defined"]},{"year":2012,"claim":"Revealed stress-dependent substrate switching: PARL dissociates from PINK1 and engages PGAM5 upon depolarization, showing the protease redirects its activity according to mitochondrial state.","evidence":"PARL knockdown, CCCP, reciprocal Co-IP of PARL with PINK1 and PGAM5, PGAM5 cleavage Western blot","pmids":["22915595"],"confidence":"High","gaps":["Molecular trigger for the switch not defined here","Downstream signaling from cleaved PGAM5 not addressed"]},{"year":2012,"claim":"Extended the OPA1/PARL cristae-remodeling pathway to adaptive stress, showing it is required for heat-shock-induced apoptotic resistance.","evidence":"Parl-/- cells, OPA1 oligomer analysis, heat-shock conditioning, cytochrome c release assay","pmids":["22579715"],"confidence":"Medium","gaps":["Signal linking heat shock to PARL/OPA1 not identified","Single-lab mechanism"]},{"year":2013,"claim":"Linked PARL-HtrA2 processing to neuronal survival after ischemia, where PARL loss disrupts HtrA2 processing and worsens injury.","evidence":"Co-IP, fractionation, PARL siRNA, and global cerebral ischemia mouse neuronal injury model","pmids":["23921894"],"confidence":"Medium","gaps":["Does not resolve the HAX1-PARL controversy","Direct catalytic cleavage versus correlative association not distinguished"]},{"year":2015,"claim":"Clarified the mitophagy mechanism by showing PARL ablation causes retrograde translocation of a PINK1 import intermediate to the outer membrane, phenocopying uncoupler-induced mitophagy.","evidence":"PARL KO, PINK1 localization fractionation, Parkin recruitment, and PINK1 mutant kinase/mitophagy analysis","pmids":["26101826"],"confidence":"High","gaps":["Machinery driving retrograde translocation not identified","Quantitative contribution of PARL versus other proteases unresolved"]},{"year":2016,"claim":"Placed PARL within a defined inner-membrane protease assembly, the SLP2-PARL-YME1L SPY complex, establishing that complex membership regulates PARL substrate processing and restrains OMA1.","evidence":"Co-IP, Blue Native PAGE, PARL/SLP2 knockdown, and PINK1/PGAM5/OPA1 processing Western blots","pmids":["27737933"],"confidence":"High","gaps":["Stoichiometry and architecture of the SPY complex not structurally defined","How SLP2 mechanistically tunes PARL activity not resolved"]},{"year":2017,"claim":"Identified Smac/DIABLO as a PARL substrate whose intramembrane cleavage generates the IAP-binding motif required for apoptosis, broadening PARL's role in cell death.","evidence":"PARL substrate proteomics, KO cells, in vitro cleavage, XIAP binding assay, and apoptosis rescue","pmids":["28288130"],"confidence":"High","gaps":["Regulation of Smac cleavage relative to PINK1/PGAM5 not defined","In vivo apoptotic contribution not quantified"]},{"year":2017,"claim":"Connected metabolic state to PARL activity by showing PDK2 phosphorylates PARL to regulate autocatalytic beta-cleavage and negatively control PINK1/Parkin mitophagy.","evidence":"PDK2 kinase assay, phospho-PARL detection, mitophagy reporter, PARL beta-cleavage Western blot","pmids":["28178523"],"confidence":"Medium","gaps":["Direct phosphosite-to-activity mapping incomplete","Single-lab finding"]},{"year":2018,"claim":"Established STARD7 as a PARL substrate whose cleavage governs phosphatidylcholine homeostasis, respiration, and cristae morphogenesis, linking PARL to membrane lipid biology.","evidence":"PARL KO cells, STARD7 fractionation, lipid analysis, cristae EM, respiration assays, sorting-signal mutagenesis","pmids":["29301859"],"confidence":"High","gaps":["Regulation of STARD7 cleavage by membrane potential not addressed","Quantitative lipid flux not measured"]},{"year":2018,"claim":"Uncovered a PINK1/PGAM5-independent neurological function of PARL in supporting Complex III activity and coenzyme Q biosynthesis via stable TTC19 and COQ4 expression.","evidence":"Nervous-system conditional Parl KO mouse, respiratory enzyme assays, CoQ HPLC, TTC19/COQ4 Western blot, EM, and PINK1/PGAM5 epistasis","pmids":["30578322"],"confidence":"High","gaps":["Whether TTC19/COQ4 are direct PARL substrates not established","Mechanism of their destabilization in PARL loss unknown"]},{"year":2019,"claim":"Defined a PHB2-PARL-PGAM5-PINK1 axis in which PHB2 binds and restrains PARL, connecting prohibitin signaling to PARL-dependent mitophagy.","evidence":"Co-IP, PARL activity assay upon PHB2 depletion, PINK1 stability, Parkin recruitment, PGAM5 processing","pmids":["31177901"],"confidence":"Medium","gaps":["Mechanism by which PHB2 inhibits PARL not defined","Single-lab finding"]},{"year":2021,"claim":"Reconstituted PARL biochemically to define intrinsic substrate specificity and cofactor dependence, showing beta-cleaved PARL is more active, cardiolipin enhances activity, and PARL prefers bulky P1 residues.","evidence":"Recombinant PARL in proteoliposomes, FRET kinetics, cardiolipin supplementation, 228-peptide substrate profiling, full-length versus beta-cleaved comparison","pmids":["33556373"],"confidence":"High","gaps":["Membrane potential gating not recapitulated in vitro","Structural basis of substrate selection not resolved"]},{"year":2022,"claim":"Resolved how PGAM5 substrate features and oligomeric state dictate PARL cleavage, defining transmembrane determinants and depolarization-triggered monomerization.","evidence":"NMR of PGAM5 TM domain, polar-residue mutagenesis, membrane-potential dissipation, oligomeric-state analysis, PARL cleavage assay","pmids":["35921890"],"confidence":"High","gaps":["Structure of the PARL-PGAM5 enzyme-substrate complex not solved","Generality of oligomer-gating to other substrates unknown"]},{"year":2022,"claim":"Demonstrated that acute pharmacological PARL inhibition robustly activates PINK1/Parkin mitophagy without major mitochondrial side effects, validating PARL as a druggable mitophagy target.","evidence":"Ketoamide inhibitor synthesis, cellular PARL inhibition, PINK1 intermediate accumulation, Parkin activation assay","pmids":["36540942"],"confidence":"Medium","gaps":["Selectivity over other rhomboids not fully characterized","In vivo efficacy not tested"]},{"year":2023,"claim":"Identified CHCHD10 as a direct PARL-suppressing interactor whose ALS/FTD mutations derepress PARL to lower PINK1 and impair mitophagy, linking PARL regulation to neurodegenerative disease.","evidence":"Co-IP, PINK1 level and Parkin recruitment assays, mouse models, and human FTD brain tissue","pmids":["38132101"],"confidence":"Medium","gaps":["Mechanism by which CHCHD10 suppresses PARL activity not defined","Single-lab finding"]},{"year":2025,"claim":"Proposed a non-proteolytic anti-apoptotic role for PARL in stabilizing Nur77-BCL-2 complexes at mitochondria via a defined alpha-helix interface.","evidence":"Co-IP of PARL-Nur77-BCL-2, AlphaFold2 modeling, PARL knockdown/Nur77 overexpression in MPTP mouse model","pmids":["41052999"],"confidence":"Low","gaps":["Structural interface is computational prediction only, not experimentally solved","Not independently replicated","Whether the role is protease-independent not biochemically confirmed"]},{"year":2025,"claim":"Suggested PARL indirectly modulates mitochondrial calcium uptake by altering MICU1/MICU2 levels without direct binding to uniporter components.","evidence":"PARL overexpression/silencing, calcium imaging, Co-IP negative for MICU1/MICU2/MCU/EMRE, Western blot of regulator levels","pmids":["40484322"],"confidence":"Low","gaps":["Mechanism linking PARL to MICU level changes not defined","No direct interaction; indirect inference only","Not independently replicated"]},{"year":null,"claim":"How PARL's membrane-potential gating of substrate selection is mechanistically transduced—and whether its emerging non-proteolytic roles (Nur77-BCL-2 scaffolding, calcium modulation) are bona fide functions—remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of PARL bound to any substrate or partner","Sensor coupling membrane potential to PARL activity unidentified","Non-proteolytic functions rest on single low-confidence studies"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[4,5,8,11,13,16]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[4,11,16]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,4,10,13,14]}],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[4,9,15,12]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,11,22]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,5,8,11,13]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,13]}],"complexes":["SPY complex (SLP2-PARL-YME1L)"],"partners":["PINK1","PGAM5","SLP2","YME1L","HTRA2","PHB2","CHCHD10","STARD7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H300","full_name":"Presenilin-associated rhomboid-like protein, mitochondrial","aliases":["Mitochondrial intramembrane cleaving protease PARL"],"length_aa":379,"mass_kda":42.2,"function":"Required for the control of apoptosis during postnatal growth. Essential for proteolytic processing of an antiapoptotic form of OPA1 which prevents the release of mitochondrial cytochrome c in response to intrinsic apoptotic signals (By similarity). Required for the maturation of PINK1 into its 52kDa mature form after its cleavage by mitochondrial-processing peptidase (MPP) (PubMed:22354088). Promotes cleavage of serine/threonine-protein phosphatase PGAM5 in damaged mitochondria in response to loss of mitochondrial membrane potential (PubMed:22915595). Mediates differential cleavage of PINK1 and PGAM5 depending on the health status of mitochondria, disassociating from PINK1 and associating with PGAM5 in response to mitochondrial membrane potential loss (PubMed:22915595). Required for processing of CLPB into a form with higher protein disaggregase activity by removing an autoinhibitory N-terminal peptide (PubMed:28288130, PubMed:32573439). Promotes processing of DIABLO/SMAC in the mitochondrion which is required for DIABLO apoptotic activity (PubMed:28288130). Also required for cleavage of STARD7 and TTC19 (PubMed:28288130). Promotes changes in mitochondria morphology regulated by phosphorylation of P-beta domain (PubMed:14732705, PubMed:17116872)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9H300/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PARL","classification":"Not Classified","n_dependent_lines":163,"n_total_lines":1208,"dependency_fraction":0.13493377483443708},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PARL","total_profiled":1310},"omim":[{"mim_id":"616712","title":"START DOMAIN-CONTAINING PROTEIN 7; STARD7","url":"https://www.omim.org/entry/616712"},{"mim_id":"616254","title":"CASEINOLYTIC PEPTIDASE B; CLPB","url":"https://www.omim.org/entry/616254"},{"mim_id":"608309","title":"PTEN-INDUCED KINASE 1; PINK1","url":"https://www.omim.org/entry/608309"},{"mim_id":"607858","title":"PRESENILIN-ASSOCIATED RHOMBOID-LIKE PROTEIN; PARL","url":"https://www.omim.org/entry/607858"},{"mim_id":"607472","title":"MITOCHONDRIAL ESCAPE 1-LIKE 1; YME1L1","url":"https://www.omim.org/entry/607472"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PARL"},"hgnc":{"alias_symbol":["PRO2207","PSARL1","RHBDS1"],"prev_symbol":["PSARL"]},"alphafold":{"accession":"Q9H300","domains":[{"cath_id":"1.20.1540.10","chopping":"96-136_165-371","consensus_level":"high","plddt":93.4492,"start":96,"end":371}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H300","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H300-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H300-F1-predicted_aligned_error_v6.png","plddt_mean":77.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PARL","jax_strain_url":"https://www.jax.org/strain/search?query=PARL"},"sequence":{"accession":"Q9H300","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H300.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H300/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H300"}},"corpus_meta":[{"pmid":"21115803","id":"PMC_21115803","title":"Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL.","date":"2010","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21115803","citation_count":1105,"is_preprint":false},{"pmid":"16839884","id":"PMC_16839884","title":"Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16839884","citation_count":604,"is_preprint":false},{"pmid":"21138942","id":"PMC_21138942","title":"PINK1 cleavage at position A103 by the mitochondrial protease PARL.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21138942","citation_count":410,"is_preprint":false},{"pmid":"31177901","id":"PMC_31177901","title":"PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31177901","citation_count":342,"is_preprint":false},{"pmid":"21426348","id":"PMC_21426348","title":"The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking.","date":"2011","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21426348","citation_count":318,"is_preprint":false},{"pmid":"18288109","id":"PMC_18288109","title":"Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons.","date":"2008","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/18288109","citation_count":218,"is_preprint":false},{"pmid":"27737933","id":"PMC_27737933","title":"The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i-AAA protease YME1L.","date":"2016","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/27737933","citation_count":155,"is_preprint":false},{"pmid":"22915595","id":"PMC_22915595","title":"Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22915595","citation_count":150,"is_preprint":false},{"pmid":"21355049","id":"PMC_21355049","title":"Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21355049","citation_count":139,"is_preprint":false},{"pmid":"28288130","id":"PMC_28288130","title":"PARL mediates Smac proteolytic maturation in mitochondria to promote apoptosis.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28288130","citation_count":125,"is_preprint":false},{"pmid":"17464328","id":"PMC_17464328","title":"A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis.","date":"2007","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/17464328","citation_count":119,"is_preprint":false},{"pmid":"26101826","id":"PMC_26101826","title":"Intramembrane protease PARL defines a negative regulator of PINK1- and PARK2/Parkin-dependent mitophagy.","date":"2015","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/26101826","citation_count":86,"is_preprint":false},{"pmid":"29301859","id":"PMC_29301859","title":"PARL partitions the lipid transfer protein STARD7 between the cytosol and mitochondria.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29301859","citation_count":83,"is_preprint":false},{"pmid":"17116872","id":"PMC_17116872","title":"Phosphorylation and cleavage of presenilin-associated rhomboid-like protein (PARL) promotes changes in mitochondrial morphology.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17116872","citation_count":76,"is_preprint":false},{"pmid":"20444421","id":"PMC_20444421","title":"Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL.","date":"2010","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20444421","citation_count":76,"is_preprint":false},{"pmid":"30578322","id":"PMC_30578322","title":"PARL deficiency in mouse causes Complex III defects, coenzyme Q depletion, and Leigh-like syndrome.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30578322","citation_count":74,"is_preprint":false},{"pmid":"15729572","id":"PMC_15729572","title":"The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes.","date":"2005","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/15729572","citation_count":66,"is_preprint":false},{"pmid":"28178523","id":"PMC_28178523","title":"The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and Metabolism.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28178523","citation_count":62,"is_preprint":false},{"pmid":"14732705","id":"PMC_14732705","title":"Self-regulated cleavage of the mitochondrial intramembrane-cleaving protease PARL yields Pbeta, a nuclear-targeted peptide.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14732705","citation_count":55,"is_preprint":false},{"pmid":"27502471","id":"PMC_27502471","title":"PARL: The mitochondrial rhomboid protease.","date":"2016","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27502471","citation_count":54,"is_preprint":false},{"pmid":"12214059","id":"PMC_12214059","title":"PAMP and PARL, two novel putative metalloproteases interacting with the COOH-terminus of Presenilin-1 and -2.","date":"2001","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/12214059","citation_count":50,"is_preprint":false},{"pmid":"16839872","id":"PMC_16839872","title":"OPA1 and PARL keep a lid on apoptosis.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16839872","citation_count":48,"is_preprint":false},{"pmid":"37042471","id":"PMC_37042471","title":"L-carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1-Parkin-dependent mitophagy through the CPT1a-PHB2-PARL pathways.","date":"2023","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37042471","citation_count":47,"is_preprint":false},{"pmid":"32320686","id":"PMC_32320686","title":"PARL Protease: A Glimpse at Intramembrane Proteolysis in the Inner Mitochondrial Membrane.","date":"2020","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32320686","citation_count":42,"is_preprint":false},{"pmid":"19680265","id":"PMC_19680265","title":"Hax1 lacks BH modules and is peripherally associated to heavy membranes: implications for Omi/HtrA2 and PARL activity in the regulation of mitochondrial stress and apoptosis.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19680265","citation_count":42,"is_preprint":false},{"pmid":"36906621","id":"PMC_36906621","title":"STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36906621","citation_count":40,"is_preprint":false},{"pmid":"20407791","id":"PMC_20407791","title":"Genome-wide linkage scan and association study of PARL to the expression of LHON families in Thailand.","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20407791","citation_count":39,"is_preprint":false},{"pmid":"37505079","id":"PMC_37505079","title":"Mitochondrial defects caused by PARL deficiency lead to arrested spermatogenesis and ferroptosis.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37505079","citation_count":31,"is_preprint":false},{"pmid":"20045481","id":"PMC_20045481","title":"The PARL family of mitochondrial rhomboid proteases.","date":"2010","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20045481","citation_count":31,"is_preprint":false},{"pmid":"33556373","id":"PMC_33556373","title":"Insights into the catalytic properties of the mitochondrial rhomboid protease PARL.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33556373","citation_count":28,"is_preprint":false},{"pmid":"22579715","id":"PMC_22579715","title":"The antiapoptotic OPA1/Parl couple participates in mitochondrial adaptation to heat shock.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22579715","citation_count":24,"is_preprint":false},{"pmid":"28641777","id":"PMC_28641777","title":"Role of PARL-PINK1-Parkin pathway in adipocyte differentiation.","date":"2017","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/28641777","citation_count":23,"is_preprint":false},{"pmid":"30744219","id":"PMC_30744219","title":"Determination of genetic stability in long-term micropropagated shoots of Pinus thunbergii Parl. using RAPD markers.","date":"1998","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30744219","citation_count":23,"is_preprint":false},{"pmid":"19185381","id":"PMC_19185381","title":"The Leu262Val polymorphism of presenilin associated rhomboid like protein (PARL) is associated with earlier onset of type 2 diabetes and increased urinary microalbumin creatinine ratio in an Irish case-control population.","date":"2009","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/19185381","citation_count":22,"is_preprint":false},{"pmid":"36540942","id":"PMC_36540942","title":"Chemical Blockage of the Mitochondrial Rhomboid Protease PARL by Novel Ketoamide Inhibitors Reveals Its Role in PINK1/Parkin-Dependent Mitophagy.","date":"2022","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36540942","citation_count":18,"is_preprint":false},{"pmid":"20711738","id":"PMC_20711738","title":"No association between the SNPs (rs3749446 and rs1402000) in the PARL gene and LHON in Chinese patients with m.11778G>A.","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20711738","citation_count":18,"is_preprint":false},{"pmid":"35860016","id":"PMC_35860016","title":"Heat Shock Transcription Factor 2 Promotes Mitophagy of Intestinal Epithelial Cells Through PARL/PINK1/Parkin Pathway in Ulcerative Colitis.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35860016","citation_count":17,"is_preprint":false},{"pmid":"19862556","id":"PMC_19862556","title":"Genetic variation in PARL influences mitochondrial content.","date":"2009","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19862556","citation_count":16,"is_preprint":false},{"pmid":"23921894","id":"PMC_23921894","title":"The role of PARL and HtrA2 in striatal neuronal injury after transient global cerebral ischemia.","date":"2013","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23921894","citation_count":15,"is_preprint":false},{"pmid":"23973714","id":"PMC_23973714","title":"Identification of the variants in PARL, the nuclear modifier gene, responsible for the expression of LHON patients in Thailand.","date":"2013","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/23973714","citation_count":12,"is_preprint":false},{"pmid":"17019603","id":"PMC_17019603","title":"PARL Leu262Val is not associated with fasting insulin levels in UK populations.","date":"2006","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/17019603","citation_count":12,"is_preprint":false},{"pmid":"35921890","id":"PMC_35921890","title":"Cleavage of mitochondrial homeostasis regulator PGAM5 by the intramembrane protease PARL is governed by transmembrane helix dynamics and oligomeric state.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35921890","citation_count":11,"is_preprint":false},{"pmid":"38132101","id":"PMC_38132101","title":"Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/38132101","citation_count":10,"is_preprint":false},{"pmid":"31877459","id":"PMC_31877459","title":"Transcriptomic analysis of selenium accumulation in Puccinellia distans (Jacq.) Parl., a boron hyperaccumulator.","date":"2019","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/31877459","citation_count":10,"is_preprint":false},{"pmid":"36870520","id":"PMC_36870520","title":"Genome-wide Survival Study Identifies PARL as a Novel Locus for Clinical Progression and Neurodegeneration in Alzheimer's Disease.","date":"2023","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/36870520","citation_count":9,"is_preprint":false},{"pmid":"32470650","id":"PMC_32470650","title":"Accumulation of HAX-1 and PARL in brainstem- and cortical-type Lewy bodies in Parkinson's disease and dementia with Lewy bodies.","date":"2020","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32470650","citation_count":8,"is_preprint":false},{"pmid":"28361942","id":"PMC_28361942","title":"PARL paves the way to apoptosis.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28361942","citation_count":8,"is_preprint":false},{"pmid":"33877619","id":"PMC_33877619","title":"Expression and Purification of Human Mitochondrial Intramembrane Protease PARL.","date":"2021","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/33877619","citation_count":6,"is_preprint":false},{"pmid":"34311087","id":"PMC_34311087","title":"Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL.","date":"2021","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/34311087","citation_count":6,"is_preprint":false},{"pmid":"37762682","id":"PMC_37762682","title":"Resistant and Susceptible Pinus thunbergii ParL. Show Highly Divergent Patterns of Differentially Expressed Genes during the Process of Infection by Bursaphelenchus xylophilus.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37762682","citation_count":6,"is_preprint":false},{"pmid":"37633053","id":"PMC_37633053","title":"Inhibition of mitochondrial fusion via SIRT1/PDK2/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/37633053","citation_count":5,"is_preprint":false},{"pmid":"18758826","id":"PMC_18758826","title":"Association of PARL rs3732581 genetic variant with insulin levels, metabolic syndrome and coronary artery disease.","date":"2008","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18758826","citation_count":5,"is_preprint":false},{"pmid":"27356235","id":"PMC_27356235","title":"Extremely high boron tolerance in Puccinellia distans (Jacq.) Parl. related to root boron exclusion and a well-regulated antioxidant system.","date":"2016","source":"Zeitschrift fur Naturforschung. C, Journal of biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/27356235","citation_count":5,"is_preprint":false},{"pmid":"38182793","id":"PMC_38182793","title":"The mitochondrial protease PARL is required for spermatogenesis.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/38182793","citation_count":4,"is_preprint":false},{"pmid":"40013375","id":"PMC_40013375","title":"Cleaving PINK1 or PGAM5? Involvement of PARL in Methamphetamine-Induced Excessive Mitophagy and Neuronal Necroptosis.","date":"2025","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/40013375","citation_count":3,"is_preprint":false},{"pmid":"33519946","id":"PMC_33519946","title":"Pinus thunbergii Parl. Extracts Reduce Acute Inflammation by Targeting Oxidative Stress.","date":"2021","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/33519946","citation_count":3,"is_preprint":false},{"pmid":"41052999","id":"PMC_41052999","title":"PARL stabilizes mitochondrial BCL-2 via Nur77-mediated scaffolding as a therapeutic strategy for Parkinson's disease.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41052999","citation_count":2,"is_preprint":false},{"pmid":"40484322","id":"PMC_40484322","title":"Impact of PARL-mediated mitochondrial protease activity on calcium regulation.","date":"2025","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/40484322","citation_count":2,"is_preprint":false},{"pmid":"38791195","id":"PMC_38791195","title":"Pinus thunbergii Parl. Somatic Plants' Resistance to Bursaphelenchus xylophilus Depends on Pathogen-Induced Differential Transcriptomic Responses.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38791195","citation_count":2,"is_preprint":false},{"pmid":"39798391","id":"PMC_39798391","title":"PARL regulates porcine oocyte meiotic maturation by mediating mitochondrial activity.","date":"2025","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/39798391","citation_count":1,"is_preprint":false},{"pmid":"25354644","id":"PMC_25354644","title":"Common variants of the PINK1 and PARL genes do not confer genetic susceptibility to schizophrenia in Han Chinese.","date":"2014","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/25354644","citation_count":1,"is_preprint":false},{"pmid":"41978920","id":"PMC_41978920","title":"Kinetochore size correlates with chromosome size in Star of Bethlehem (Ornithogalum kochii Parl., Asparagaceae).","date":"2026","source":"Plant biology (Stuttgart, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41978920","citation_count":0,"is_preprint":false},{"pmid":"39702005","id":"PMC_39702005","title":"Establishment of embryogenic Pinus thunbergii Parl. suspension cultures: growth parameters, dynamic analysis, and plant regenerative capacities.","date":"2024","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/39702005","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.24.684163","title":"Exploring the Repertoire of Rhomboid Proteases in  <i>Cryptosporidium parvum</i>  Parasite: Phylogenesis, Structural motifs and Cellular Localization in Sporozoite Cells","date":"2025-10-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.24.684163","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.06.622366","title":"Alternative Import-Channels And Destinations Of Mitochondrial PINK1 Controlled By Trans-Membrane-Domain Structural Plasticity","date":"2024-11-06","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.06.622366","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.24.645073","title":"Substrate recognition by the human mitochondrial processing peptidase and its processing of PINK1","date":"2025-03-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.24.645073","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.01.24314751","title":"Causal links between mitophagy and Alzheimer’s disease: a Mendelian randomization study","date":"2024-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.01.24314751","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":32769,"output_tokens":6445,"usd":0.097491,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15308,"output_tokens":6751,"usd":0.122658,"stage2_stop_reason":"end_turn"},"total_usd":0.220149,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"PARL, an inner mitochondrial membrane rhomboid protease, is required for the generation of a soluble intermembrane space (IMS) form of OPA1; loss of PARL results in reduced IMS-OPA1, faster apoptotic cristae remodeling, and increased cytochrome c release, placing PARL upstream of OPA1-dependent cristae remodeling in the intrinsic apoptosis pathway.\",\n      \"method\": \"Parl knockout mouse (Parl-/- cells), OPA1 fractionation, cytochrome c release assay, complementation with IMS-targeted OPA1\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic rescue (IMS-OPA1 complementation), KO phenotype with multiple orthogonal readouts (cristae morphology, cytochrome c release, OPA1 fractionation), replicated conceptually in multiple subsequent studies\",\n      \"pmids\": [\"16839884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PARL undergoes autocatalytic cleavage at two N-terminal sites (alpha-site at positions 52-53 and beta-site at positions 77-78); beta-cleavage is developmentally controlled, dependent on PARL I-CliP activity supplied in trans, and releases a nuclear-targeted peptide called Pbeta.\",\n      \"method\": \"Site-directed mutagenesis of cleavage sites, in vitro cleavage assay, subcellular fractionation, nuclear localization tracking of Pbeta\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis and fractionation in single study; Pbeta nuclear targeting demonstrated but functional consequence not fully established\",\n      \"pmids\": [\"14732705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Phosphorylation of three residues in the vertebrate-specific Pbeta domain of PARL (Ser-65, Thr-69, Ser-70) impairs beta-cleavage at position Ser77-Ala78 that is required for PARL-induced mitochondrial fragmentation; thus phosphorylation state of the Pbeta domain regulates PARL proteolytic activity and mitochondrial morphology.\",\n      \"method\": \"Phosphomimetic and phospho-ablative mutagenesis of PARL, mitochondrial morphology imaging, in-cell cleavage assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with functional readout (mitochondrial morphology), single lab, two orthogonal methods\",\n      \"pmids\": [\"17116872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PARL forms a complex with HAX1 and HtrA2; HAX1 presents HtrA2 to PARL, which cleaves/processes HtrA2 to its active form in the mitochondrial intermembrane space, and processed HtrA2 prevents Bax-dependent apoptosis in lymphocytes and neurons.\",\n      \"method\": \"Co-immunoprecipitation, Hax1 and Parl knockout mice, lymphocyte and neuronal apoptosis assays, HtrA2 processing Western blot\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse models with defined phenotype, Co-IP; contested by a subsequent study (PMID:19680265) arguing HAX1-PARL interaction is artifactual, lowering confidence\",\n      \"pmids\": [\"18288109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PARL mediates cleavage of PINK1 in a mitochondrial membrane potential-dependent manner; in healthy mitochondria with intact potential, PARL cleaves PINK1 to generate a ~60 kDa form inside mitochondria; upon membrane potential dissipation, PARL-mediated cleavage is blocked and full-length PINK1 (63 kDa) accumulates on the outer mitochondrial membrane where it recruits Parkin.\",\n      \"method\": \"PARL knockdown (siRNA/KO cells), membrane potential dissipation (CCCP), PINK1 Western blot, mitochondrial fractionation, Parkin recruitment assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with defined molecular phenotype, replicated by multiple independent groups (PMIDs 21138942, 21426348, 21355049)\",\n      \"pmids\": [\"21115803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PINK1 is cleaved by PARL between amino acids Ala-103 and Phe-104 to generate ΔN-PINK1; PINK1 physically interacts with PARL; loss of PARL results in aberrant PINK1 cleavage; N-terminal PD-associated PINK1 mutations alter the ratio of full-length to ΔN-PINK1.\",\n      \"method\": \"N-terminal sequencing of cleavage products, PARL knockdown, Co-immunoprecipitation of PINK1 and PARL, PD mutant analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — cleavage site mapped by N-terminal sequencing, Co-IP, loss-of-function, multiple independent replications\",\n      \"pmids\": [\"21138942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PARL cleaves PINK1 within its conserved transmembrane membrane anchor, releasing mature PINK1 into the cytosol or IMS; depolarization blocks canonical PINK1 import and PARL-catalyzed processing; two PD-causing PINK1 mutations decrease PARL-mediated processing.\",\n      \"method\": \"In-cell cleavage assay, membrane potential dissipation, PARL KO/knockdown, PINK1 localization imaging\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods, consistent with parallel independent reports, transmembrane cleavage site established\",\n      \"pmids\": [\"21426348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PARL's catalytic activity is required for normal PINK1 proteolytic processing and localization; PARL deficiency impairs PARKIN recruitment to mitochondria; a novel PARL missense mutation found in PD patients in a functional domain of the PARL N-terminus is insufficient to rescue PARKIN recruitment.\",\n      \"method\": \"Catalytically dead PARL mutant, PARL knockdown, PARKIN recruitment assay, PINK1 localization fractionation\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — catalytic mutant rescue experiment, PARKIN recruitment functional readout, human PD mutation validation\",\n      \"pmids\": [\"21355049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PARL cleaves PGAM5 in its N-terminal transmembrane domain in response to mitochondrial membrane potential loss; PARL dissociates from PINK1 and reciprocally associates with PGAM5 upon membrane potential loss, demonstrating stress-dependent substrate switching.\",\n      \"method\": \"PARL knockdown, membrane potential dissipation (CCCP), Co-immunoprecipitation of PARL with PINK1 and PGAM5, PGAM5 cleavage Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP demonstrating substrate switch, loss-of-function, multiple readouts in single study\",\n      \"pmids\": [\"22915595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Ablation of PARL causes retrograde translocation of a PINK1 import intermediate from the IMS; this intermediate is rerouted to the outer mitochondrial membrane to recruit PARK2/Parkin, phenocopying mitophagy induction by uncoupling agents; pathogenic PINK1 mutants not cleaved by PARL show reduced kinase activity and impaired PARK2-mediated mitophagy.\",\n      \"method\": \"PARL knockout, PINK1 localization fractionation, Parkin recruitment assay, PINK1 mutant analysis\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO with defined retrograde translocation mechanism, multiple PINK1 mutants tested, consistent with prior independent studies\",\n      \"pmids\": [\"26101826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SLP2 anchors a large protease complex (SPY complex: SLP2-PARL-YME1L) at the mitochondrial inner membrane; association with SLP2 regulates PARL-mediated processing of PINK1 and PGAM5; SLP2 also restricts OMA1 activity, preventing OMA1-mediated PGAM5 and OPA1 cleavage under non-stress conditions.\",\n      \"method\": \"Co-immunoprecipitation, Blue Native PAGE, PARL/SLP2 knockdown, PINK1/PGAM5/OPA1 processing Western blot\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, native complex isolation, multiple substrates tested, functional consequence of complex disruption shown\",\n      \"pmids\": [\"27737933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PARL cleaves the pro-apoptotic protein Smac/DIABLO by intramembrane proteolysis, generating an N-terminal IAP-binding motif required for Smac's apoptotic activity; loss of PARL impairs Smac proteolytic maturation and prevents Smac from binding XIAP, reducing apoptosis.\",\n      \"method\": \"PARL-based proteomics/substrate screen, PARL KO cells, in vitro cleavage assay, XIAP binding assay, apoptosis rescue with Smac peptidomimetics or cytosolic cleaved Smac\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — proteomics-based substrate identification, in vitro cleavage, KO rescue, XIAP binding assay; multiple orthogonal methods\",\n      \"pmids\": [\"28288130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PDK2 phosphorylates PARL and regulates its N-terminal autocatalytic beta-cleavage in response to mitochondrial ATP depletion; beta-cleavage produces a less active PARL form (PACT), and PDK2-mediated phosphorylation negatively regulates PINK1/PARKIN-dependent mitophagy through this mechanism.\",\n      \"method\": \"PDK2 kinase assay with PARL substrate, phospho-PARL detection, mitophagy reporter assay, PARL beta-cleavage Western blot\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase assay and functional mitophagy readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"28178523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PARL cleaves the lipid transfer protein STARD7 during mitochondrial import; cleavage partitions STARD7 between the cytosol and the mitochondrial IMS; negatively charged residues in STARD7 serve as a sorting signal; mitochondrial STARD7 is necessary for phosphatidylcholine accumulation in the inner membrane and for maintenance of respiration and cristae morphogenesis.\",\n      \"method\": \"PARL KO cells, STARD7 fractionation, phosphatidylcholine lipid analysis, cristae morphology EM, respiratory chain assay, STARD7 sorting signal mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO with multiple orthogonal functional readouts (lipid analysis, EM, respiration), mutagenesis of sorting signal, single study with comprehensive mechanistic follow-up\",\n      \"pmids\": [\"29301859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PARL deficiency in mouse causes defects in Complex III activity and coenzyme Q biosynthesis in the nervous system; PARL is required for stable expression of TTC19 (required for Complex III activity) and COQ4 (essential for CoQ biosynthesis); genetic modification of PINK1 or PGAM5 does not rescue this neurological phenotype.\",\n      \"method\": \"Conditional Parl KO mouse (nervous system-specific), respiratory chain enzyme activity assay, CoQ HPLC measurement, TTC19/COQ4 protein levels by Western blot, electron microscopy\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO mouse with multiple biochemical readouts, epistasis experiment (PINK1/PGAM5 double KO), multiple orthogonal methods\",\n      \"pmids\": [\"30578322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PHB2-mediated mitophagy is dependent on PARL; PHB2 physically interacts with PARL; PHB2 depletion activates PARL, which processes PGAM5; the PHB2-PARL-PGAM5-PINK1 axis constitutes a novel pathway for PHB2-mediated mitophagy.\",\n      \"method\": \"Co-immunoprecipitation of PHB2 and PARL, PARL activity assay upon PHB2 depletion, PINK1 stability assay, Parkin recruitment, PGAM5 processing Western blot\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, loss-of-function, functional mitophagy readout, single lab\",\n      \"pmids\": [\"31177901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Purified recombinant human PARL in proteoliposomes cleaves PINK1, PGAM5, and Smac/DIABLO; PARL activity is enhanced by cardiolipin; the beta-cleavage truncated form of PARL is more active than full-length for all three substrates; PARL prefers substrates with a bulky side chain (Phe) at the P1 position, distinct from bacterial rhomboids.\",\n      \"method\": \"In vitro reconstitution of PARL in proteoliposomes, FRET-based kinetic assay, cardiolipin supplementation, multiplex peptide substrate profiling (228 peptides), comparison of full-length vs beta-cleaved PARL\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with kinetic characterization, substrate preference profiling with 228 peptides, multiple substrates and PARL forms tested\",\n      \"pmids\": [\"33556373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PGAM5 cleavage by PARL is governed by polar transmembrane residues distant from the cleavage site; an N-terminal amphipathic helix followed by a kink and C-terminal transmembrane helix harboring the scissile bond are key for productive PARL interaction; membrane potential uncoupling triggers PGAM5 disassembly from oligomers to monomers, which are then cleaved by PARL.\",\n      \"method\": \"NMR structural analysis of PGAM5 transmembrane domain, site-directed mutagenesis of polar residues, membrane potential dissipation, PGAM5 oligomeric state analysis, PARL cleavage assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural analysis combined with mutagenesis and functional cleavage assay, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"35921890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Pharmacological inhibition of PARL using novel ketoamide inhibitors leads to robust activation of the PINK1/Parkin pathway without major secondary effects on mitochondrial properties, demonstrating that acute PARL inhibition (as opposed to genetic deficiency) is sufficient to boost PINK1/Parkin-dependent mitophagy.\",\n      \"method\": \"Ketoamide inhibitor synthesis, PARL inhibition in cells, PINK1 intermediate accumulation Western blot, Parkin activation assay\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chemical biology approach with functional readouts, single study, two methods\",\n      \"pmids\": [\"36540942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CHCHD10 wild-type suppresses PARL activity through direct interaction with PARL, stabilizing PINK1 levels; ALS/FTD-linked CHCHD10 mutations (R15L and S59L) reduce PINK1 levels by increasing PARL activity; CHCHD10 mutations impair mitophagy flux and mitochondrial Parkin recruitment.\",\n      \"method\": \"Co-immunoprecipitation of CHCHD10 and PARL, PINK1 level assay, Parkin recruitment assay, in vivo mouse models, human FTD brain tissue analysis\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, in vivo models, human tissue validation, single lab\",\n      \"pmids\": [\"38132101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In vivo, HAX1 and PARL are confined to distinct cellular compartments, and their in vitro interaction is artifactual; the mechanistic coupling of HAX1 to PARL as proposed by Chao et al. is not supported by in vivo evidence.\",\n      \"method\": \"Subcellular fractionation, in vivo co-immunoprecipitation, sequence/secondary structure analysis\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — fractionation and in vivo Co-IP as negative/contradictory evidence, single lab; contradicts PMID:18288109\",\n      \"pmids\": [\"19680265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PARL binds HtrA2 in mitochondria of normal neurons; after cerebral ischemia, PARL expression decreases, PARL-HtrA2 binding is lost, processed HtrA2 is reduced in mitochondria and released into cytosol where it binds XIAP; PARL siRNA inhibits HtrA2 processing and worsens ischemic neuronal injury.\",\n      \"method\": \"Co-immunoprecipitation of PARL and HtrA2, subcellular fractionation, siRNA knockdown, neuronal injury assay in global cerebral ischemia mouse model\",\n      \"journal\": \"Journal of cerebral blood flow and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, siRNA KD with functional phenotype, in vivo model; single lab\",\n      \"pmids\": [\"23921894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In Parl-/- cells, accumulation of IMS-OPA1 upon mild heat shock conditioning is blunted, preventing the increase in OPA1 oligomers and the acquisition of cellular resistance to subsequent apoptotic stimuli; the OPA1/PARL-dependent pathway of cristae remodeling is required for the heat shock adaptive response.\",\n      \"method\": \"Parl-/- cells, OPA1 fractionation, OPA1 oligomer analysis, heat shock conditioning protocol, cytochrome c release assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO cells with defined mechanistic pathway, single lab, two orthogonal methods\",\n      \"pmids\": [\"22579715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PARL interacts with the orphan nuclear receptor Nur77 at the mitochondria; Nur77 stabilizes PARL-BCL-2 complexes to suppress apoptosis; AlphaFold2 structural modeling identified a PARL alpha-helix essential for Nur77 binding; disrupting this interface abolishes BCL-2 stabilization and promotes neuronal death.\",\n      \"method\": \"Co-immunoprecipitation of PARL-Nur77-BCL-2, AlphaFold2 structural modeling, PARL knockdown and Nur77 overexpression in MPTP mouse model, subcellular tracking of Nur77\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP and in vivo rescue but structural data is computational prediction only, single lab, mechanistic novelty not yet replicated\",\n      \"pmids\": [\"41052999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PARL modulation (overexpression or silencing) significantly affects mitochondrial calcium uptake without influencing cytosolic calcium transients or mitochondrial membrane potential; PARL does not directly interact with MICU1 or MICU2 (mtCU regulators), but alters their protein levels in monomeric or dimeric forms, suggesting indirect modulation of the mitochondrial calcium uniporter complex.\",\n      \"method\": \"PARL overexpression and silencing, mitochondrial and cytosolic calcium imaging, Co-immunoprecipitation for MICU1/MICU2/MCU/EMRE interaction, Western blot for protein levels\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, Co-IP negative for direct interaction, indirect mechanism inferred from protein level changes without mechanistic detail\",\n      \"pmids\": [\"40484322\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PARL is a mitochondrial inner membrane serine rhomboid intramembrane protease (with a catalytic Ser/His dyad) that cleaves multiple substrates—including PINK1 (at Ala103-Phe104), PGAM5, Smac/DIABLO, STARD7, OPA1, and HtrA2—in a manner regulated by mitochondrial membrane potential, cardiolipin, and N-terminal autocatalytic beta-cleavage (itself controlled by PDK2 phosphorylation); by cleaving PINK1 in healthy mitochondria PARL promotes PINK1 degradation and suppresses mitophagy, while membrane potential dissipation blocks PARL-mediated PINK1 processing and allows full-length PINK1 to accumulate on the outer membrane and recruit Parkin for mitophagy; PARL also generates IMS-OPA1 to prevent cristae remodeling and apoptotic cytochrome c release, processes Smac to produce its IAP-binding motif for caspase activation, cleaves STARD7 to regulate phosphatidylcholine homeostasis and cristae integrity, and is organized into the SPY complex with SLP2 and YME1L that coordinates substrate selection and IM protease activity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PARL is a serine rhomboid intramembrane protease of the mitochondrial inner membrane that controls mitochondrial quality control, cristae integrity, and apoptosis by regulated cleavage of multiple membrane-embedded substrates [#4, #16]. Its central role in mitophagy lies in PINK1 processing: in healthy mitochondria with intact membrane potential, PARL cleaves PINK1 within its transmembrane anchor between Ala103 and Phe104 to generate a truncated form destined for degradation, whereas membrane potential dissipation blocks this cleavage, allowing full-length PINK1 to accumulate on the outer membrane and recruit Parkin to drive mitophagy [#4, #5, #6, #9]. Loss of PARL catalytic activity impairs PINK1 processing and Parkin recruitment, and PARL-resistant PD-associated PINK1 mutants show reduced kinase activity and defective mitophagy [#7, #9]. PARL operates as a stress-responsive substrate switch, dissociating from PINK1 and reciprocally engaging PGAM5 upon membrane potential loss, with PGAM5 cleavage further gated by its oligomeric state and transmembrane architecture [#8, #17]. Beyond mitophagy, PARL generates the soluble IMS form of OPA1 that restrains apoptotic cristae remodeling and cytochrome c release [#0], and it cleaves Smac/DIABLO to expose its IAP-binding motif required for XIAP engagement and apoptosis [#11], and STARD7 to partition this lipid-transfer protein and sustain inner-membrane phosphatidylcholine, respiration, and cristae morphogenesis [#13]. PARL activity is set by N-terminal autocatalytic beta-cleavage—which yields a more active enzyme—modulated by cardiolipin and by PDK2-dependent phosphorylation of the Pbeta domain [#12, #16, #2]. PARL functions within the SPY complex with SLP2 and YME1L, which coordinates substrate selection and restricts competing OMA1 activity [#10]. In mouse nervous system, PARL is additionally required for Complex III function and coenzyme Q biosynthesis through stable expression of TTC19 and COQ4, independent of PINK1 or PGAM5 [#14].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that PARL is itself a substrate of its own protease activity, undergoing autocatalytic N-terminal processing that liberates a nuclear-targeted peptide, setting up the idea that PARL activity is self-regulated.\",\n      \"evidence\": \"Site-directed mutagenesis of alpha/beta cleavage sites, in vitro cleavage, and fractionation tracking the Pbeta peptide\",\n      \"pmids\": [\"14732705\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of nuclear Pbeta not established\", \"How beta-cleavage alters protease activity on substrates not yet defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined PARL's first physiological substrate axis by showing it generates soluble IMS-OPA1 to oppose apoptotic cristae remodeling, placing PARL upstream of intrinsic apoptosis.\",\n      \"evidence\": \"Parl-/- cells, OPA1 fractionation, cytochrome c release assay, IMS-OPA1 complementation rescue\",\n      \"pmids\": [\"16839884\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cleavage site within OPA1 by PARL not mapped here\", \"Relationship to other OPA1-processing proteases unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed PARL activity is regulated by phosphorylation of its vertebrate-specific Pbeta domain, linking beta-cleavage to control of mitochondrial morphology.\",\n      \"evidence\": \"Phosphomimetic/phospho-ablative PARL mutagenesis with mitochondrial morphology imaging and in-cell cleavage assay\",\n      \"pmids\": [\"17116872\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase responsible not identified in this study\", \"Direct biochemical link between morphology and specific substrate cleavage not shown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Proposed PARL processes HtrA2 in an HAX1-presented manner to suppress apoptosis, extending PARL substrates to a pro-apoptotic serine protease.\",\n      \"evidence\": \"Co-IP, Hax1 and Parl knockout mice, lymphocyte/neuronal apoptosis and HtrA2 processing assays\",\n      \"pmids\": [\"18288109\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"HAX1-PARL interaction contested as artifactual by a later study\", \"Direct catalytic cleavage of HtrA2 by PARL not reconstituted\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Challenged the HAX1-PARL model by showing the two proteins occupy distinct compartments and interact only artifactually in vitro, qualifying the proposed coupling.\",\n      \"evidence\": \"Subcellular fractionation, in vivo Co-IP, and sequence/structure analysis as contradictory evidence\",\n      \"pmids\": [\"19680265\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not exclude PARL-HtrA2 interaction independent of HAX1\", \"Single-lab negative result\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified PINK1 as a membrane-potential-gated PARL substrate, providing the molecular switch that couples mitochondrial health to PINK1 stability and Parkin recruitment.\",\n      \"evidence\": \"PARL knockdown/KO, CCCP depolarization, PINK1 Western blot, fractionation, and Parkin recruitment; cleavage site mapped at Ala103-Phe104 by N-terminal sequencing\",\n      \"pmids\": [\"21115803\", \"21138942\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Fate of cleaved PINK1 fragment and its degradation route only partially defined\", \"How depolarization mechanistically blocks cleavage not fully resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Confirmed PARL cleaves PINK1 within its transmembrane anchor and that catalytic activity is required for proper PINK1 localization and Parkin recruitment, with PD mutations impinging on this processing.\",\n      \"evidence\": \"Catalytically dead PARL mutant, in-cell cleavage assays, PINK1 localization fractionation, Parkin recruitment, and human PD missense mutation analysis\",\n      \"pmids\": [\"21426348\", \"21355049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Disease causality of the PARL missense variant not established beyond functional assay\", \"Precise topology of mature PINK1 after release not fully defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed stress-dependent substrate switching: PARL dissociates from PINK1 and engages PGAM5 upon depolarization, showing the protease redirects its activity according to mitochondrial state.\",\n      \"evidence\": \"PARL knockdown, CCCP, reciprocal Co-IP of PARL with PINK1 and PGAM5, PGAM5 cleavage Western blot\",\n      \"pmids\": [\"22915595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular trigger for the switch not defined here\", \"Downstream signaling from cleaved PGAM5 not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended the OPA1/PARL cristae-remodeling pathway to adaptive stress, showing it is required for heat-shock-induced apoptotic resistance.\",\n      \"evidence\": \"Parl-/- cells, OPA1 oligomer analysis, heat-shock conditioning, cytochrome c release assay\",\n      \"pmids\": [\"22579715\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signal linking heat shock to PARL/OPA1 not identified\", \"Single-lab mechanism\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Linked PARL-HtrA2 processing to neuronal survival after ischemia, where PARL loss disrupts HtrA2 processing and worsens injury.\",\n      \"evidence\": \"Co-IP, fractionation, PARL siRNA, and global cerebral ischemia mouse neuronal injury model\",\n      \"pmids\": [\"23921894\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not resolve the HAX1-PARL controversy\", \"Direct catalytic cleavage versus correlative association not distinguished\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Clarified the mitophagy mechanism by showing PARL ablation causes retrograde translocation of a PINK1 import intermediate to the outer membrane, phenocopying uncoupler-induced mitophagy.\",\n      \"evidence\": \"PARL KO, PINK1 localization fractionation, Parkin recruitment, and PINK1 mutant kinase/mitophagy analysis\",\n      \"pmids\": [\"26101826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Machinery driving retrograde translocation not identified\", \"Quantitative contribution of PARL versus other proteases unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Placed PARL within a defined inner-membrane protease assembly, the SLP2-PARL-YME1L SPY complex, establishing that complex membership regulates PARL substrate processing and restrains OMA1.\",\n      \"evidence\": \"Co-IP, Blue Native PAGE, PARL/SLP2 knockdown, and PINK1/PGAM5/OPA1 processing Western blots\",\n      \"pmids\": [\"27737933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and architecture of the SPY complex not structurally defined\", \"How SLP2 mechanistically tunes PARL activity not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified Smac/DIABLO as a PARL substrate whose intramembrane cleavage generates the IAP-binding motif required for apoptosis, broadening PARL's role in cell death.\",\n      \"evidence\": \"PARL substrate proteomics, KO cells, in vitro cleavage, XIAP binding assay, and apoptosis rescue\",\n      \"pmids\": [\"28288130\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of Smac cleavage relative to PINK1/PGAM5 not defined\", \"In vivo apoptotic contribution not quantified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Connected metabolic state to PARL activity by showing PDK2 phosphorylates PARL to regulate autocatalytic beta-cleavage and negatively control PINK1/Parkin mitophagy.\",\n      \"evidence\": \"PDK2 kinase assay, phospho-PARL detection, mitophagy reporter, PARL beta-cleavage Western blot\",\n      \"pmids\": [\"28178523\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct phosphosite-to-activity mapping incomplete\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established STARD7 as a PARL substrate whose cleavage governs phosphatidylcholine homeostasis, respiration, and cristae morphogenesis, linking PARL to membrane lipid biology.\",\n      \"evidence\": \"PARL KO cells, STARD7 fractionation, lipid analysis, cristae EM, respiration assays, sorting-signal mutagenesis\",\n      \"pmids\": [\"29301859\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of STARD7 cleavage by membrane potential not addressed\", \"Quantitative lipid flux not measured\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Uncovered a PINK1/PGAM5-independent neurological function of PARL in supporting Complex III activity and coenzyme Q biosynthesis via stable TTC19 and COQ4 expression.\",\n      \"evidence\": \"Nervous-system conditional Parl KO mouse, respiratory enzyme assays, CoQ HPLC, TTC19/COQ4 Western blot, EM, and PINK1/PGAM5 epistasis\",\n      \"pmids\": [\"30578322\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TTC19/COQ4 are direct PARL substrates not established\", \"Mechanism of their destabilization in PARL loss unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a PHB2-PARL-PGAM5-PINK1 axis in which PHB2 binds and restrains PARL, connecting prohibitin signaling to PARL-dependent mitophagy.\",\n      \"evidence\": \"Co-IP, PARL activity assay upon PHB2 depletion, PINK1 stability, Parkin recruitment, PGAM5 processing\",\n      \"pmids\": [\"31177901\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which PHB2 inhibits PARL not defined\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Reconstituted PARL biochemically to define intrinsic substrate specificity and cofactor dependence, showing beta-cleaved PARL is more active, cardiolipin enhances activity, and PARL prefers bulky P1 residues.\",\n      \"evidence\": \"Recombinant PARL in proteoliposomes, FRET kinetics, cardiolipin supplementation, 228-peptide substrate profiling, full-length versus beta-cleaved comparison\",\n      \"pmids\": [\"33556373\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Membrane potential gating not recapitulated in vitro\", \"Structural basis of substrate selection not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolved how PGAM5 substrate features and oligomeric state dictate PARL cleavage, defining transmembrane determinants and depolarization-triggered monomerization.\",\n      \"evidence\": \"NMR of PGAM5 TM domain, polar-residue mutagenesis, membrane-potential dissipation, oligomeric-state analysis, PARL cleavage assay\",\n      \"pmids\": [\"35921890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the PARL-PGAM5 enzyme-substrate complex not solved\", \"Generality of oligomer-gating to other substrates unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated that acute pharmacological PARL inhibition robustly activates PINK1/Parkin mitophagy without major mitochondrial side effects, validating PARL as a druggable mitophagy target.\",\n      \"evidence\": \"Ketoamide inhibitor synthesis, cellular PARL inhibition, PINK1 intermediate accumulation, Parkin activation assay\",\n      \"pmids\": [\"36540942\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Selectivity over other rhomboids not fully characterized\", \"In vivo efficacy not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified CHCHD10 as a direct PARL-suppressing interactor whose ALS/FTD mutations derepress PARL to lower PINK1 and impair mitophagy, linking PARL regulation to neurodegenerative disease.\",\n      \"evidence\": \"Co-IP, PINK1 level and Parkin recruitment assays, mouse models, and human FTD brain tissue\",\n      \"pmids\": [\"38132101\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which CHCHD10 suppresses PARL activity not defined\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Proposed a non-proteolytic anti-apoptotic role for PARL in stabilizing Nur77-BCL-2 complexes at mitochondria via a defined alpha-helix interface.\",\n      \"evidence\": \"Co-IP of PARL-Nur77-BCL-2, AlphaFold2 modeling, PARL knockdown/Nur77 overexpression in MPTP mouse model\",\n      \"pmids\": [\"41052999\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Structural interface is computational prediction only, not experimentally solved\", \"Not independently replicated\", \"Whether the role is protease-independent not biochemically confirmed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Suggested PARL indirectly modulates mitochondrial calcium uptake by altering MICU1/MICU2 levels without direct binding to uniporter components.\",\n      \"evidence\": \"PARL overexpression/silencing, calcium imaging, Co-IP negative for MICU1/MICU2/MCU/EMRE, Western blot of regulator levels\",\n      \"pmids\": [\"40484322\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanism linking PARL to MICU level changes not defined\", \"No direct interaction; indirect inference only\", \"Not independently replicated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PARL's membrane-potential gating of substrate selection is mechanistically transduced—and whether its emerging non-proteolytic roles (Nur77-BCL-2 scaffolding, calcium modulation) are bona fide functions—remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of PARL bound to any substrate or partner\", \"Sensor coupling membrane potential to PARL activity unidentified\", \"Non-proteolytic functions rest on single low-confidence studies\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4, 5, 8, 11, 13, 16]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [4, 11, 16]},\n      {\"term_id\": \"GO:0008233\", \"supporting_discovery_ids\": []}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005743\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 4, 10, 13, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [4, 9, 15, 12]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 11, 22]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 5, 8, 11, 13]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 13]}\n    ],\n    \"complexes\": [\"SPY complex (SLP2-PARL-YME1L)\"],\n    \"partners\": [\"PINK1\", \"PGAM5\", \"SLP2\", \"YME1L\", \"HtrA2\", \"PHB2\", \"CHCHD10\", \"STARD7\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}